Skip to main content

and
  1. Article

    Open Access

    Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice

    Muscular dystrophy is a group of genetic disorders that lead to muscle wasting and loss of muscle function. Identifying genetic modifiers that alleviate symptoms or enhance the severity of a primary disease he...

    Paula Zarén, Kinga I. Gawlik in Scientific Reports (2024)

  2. Article

    Open Access

    Early skeletal muscle pathology and disease progress in the dy3K/dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency

    Deficiency of laminin α2 chain leads to a severe form of congenital muscular dystrophy (LAMA2-CMD), and dystrophic symptoms progress rapidly in early childhood. Currently, there is no treatment for this detrim...

    Kinga I. Gawlik, Zandra Körner, Bruno M. Oliveira, Madeleine Durbeej in Scientific Reports (2019)

  3. No Access

    Article

    A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene

    Neuromuscular disorders are often caused by heterogeneous mutations in large, structurally complex genes. Targeting compensatory modifier genes could be beneficial to improve disease phenotypes. Here we report...

    Dwi U. Kemaladewi, Prabhpreet S. Bassi, Steven Erwood, Dhekra Al-Basha in Nature (2019)

  4. Article

    Open Access

    Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy

    A large number of human diseases are caused by chronic tissue injury with fibrosis potentially leading to organ failure. There is a need for more effective anti-fibrotic therapies. Congenital muscular dystroph...

    Kinga I. Gawlik, Johan Holmberg, Martina Svensson, Mikaela Einerborg in Scientific Reports (2017)

  5. Article

    Open Access

    Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice

    Laminin-211 is a major constituent of the skeletal muscle basement membrane, exerting its biological functions by binding to cell surface receptors integrin α7β1 and dystroglycan (the latter is part of the dys...

    Kinga I. Gawlik, Madeleine Durbeej in Scientific Reports (2015)

  6. Article

    Open Access

    Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies

    Laminin-211 is a cell-adhesion molecule that is strongly expressed in the basement membrane of skeletal muscle. By binding to the cell surface receptors dystroglycan and integrin α7β1, laminin-211 is believed ...

    Kinga I Gawlik, Madeleine Durbeej in Skeletal Muscle (2011)